In melanoma cell lines as well as dendritic cells (DC), experimental overexpression of CTNNB1 has been shown to increase interleukin (IL) IL-10 secretion and to impede the ability of DCs to cross-prime tumour-targeting CD8+ T cells (30). Here, CTNNB1 is linked to neoplasm.